Medicaments and Methods for Inhibition of Scarring

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110082171A1
SERIAL NO

12995900

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

receptor, such as Gaboxadol (7-tetra hydroisoxazolo[5,4-c]pyridin-3-ol), or a pharmaceutically acceptable salt thereof. The scarring to be prevented, reduced or inhibited may be scarring formed on healing of a wound of the dermis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RENOVO LIMITEDMANCHESTER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferguson, Mark William James Manchester, GB 36 266
Goldspink, Nick Manchester, GB 1 3
Nield, Kerry Manchester, GB 11 34
O'Kane, Sharon Manchester, GB 32 103
Occleston, Nicholas Manchester, GB 14 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation